STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[Form 4] Life360, Inc. Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

John Philip Coghlan, a director of Life360, Inc. (LIF), reported multiple dispositions of common stock effected on 10/01/2025. The filing shows sales under a Rule 10b5-1 trading plan adopted on 12/06/2024. Reported transactions include dispositions of 2,701 shares at a weighted average price of $105.28 (prices ranged $104.84$105.73), 424 shares at a weighted average of $105.99 (range $105.84$106.05), and 3,344 shares (note: includes 2,508 restricted stock units) with beneficial ownership changes reported as indirect holdings in the John Coghlan Living Trust and the John Philip Coghlan 2025 Grantor Retained Annuity Trust. The Form 4 was signed by an attorney-in-fact on 10/03/2025.

Positive

  • Dispositions executed under a Rule 10b5-1 plan adopted on 12/06/2024
  • Price ranges and weighted averages disclosed (e.g., $104.84$105.73, $105.84$106.05)

Negative

  • Director reported multiple sales of common stock on 10/01/2025 (2,701; 424; 3,344 shares)
  • 3,344-share disposition includes 2,508 restricted stock units, reducing potential future vested holdings

Insights

Director sold shares under a pre-set 10b5-1 plan, reporting multiple dispositions at roughly $105 per share.

The Form 4 discloses sales on 10/01/2025 executed via a Rule 10b5-1 plan adopted on 12/06/2024, indicating the trades were pre-arranged and executed automatically. The filing lists weighted average prices and inclusive price ranges for the transactions.

This matters because 10b5-1 sales are generally pre-planned, which reduces the likelihood that the sales were based on material nonpublic information, though the market often interprets insider sales as useful context.

Dispositions are held indirectly through trusts, and a portion arose from restricted stock units.

The filing shows indirect holdings in the John Coghlan Living Trust and the John Philip Coghlan 2025 Grantor Retained Annuity Trust, and notes 2,508 restricted stock units included in a reported disposition. The use of trusts and RSUs is common for executive holdings and tax/estate planning.

Investors can confirm the mechanics (trusts, RSUs, and 10b5-1 plan) from the disclosed text; no additional corporate actions or compensation changes are reported here.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
COGHLAN JOHN PHILIP

(Last) (First) (Middle)
C/O LIFE360, INC.
1900 SOUTH NORFOLK STREET, SUITE 310

(Street)
SAN MATEO CA 94403

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Life360, Inc. [ LIF ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
10/01/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common stock 10/01/2025 S(1) 2,701 D $105.28(2) 6,674 I Held by the John Coghlan Living Trust
Common stock 10/01/2025 S(1) 424 D $105.99(3) 6,250 I Held by the John Coghlan Living Trust
Common stock 3,344(4) D
Common Stock 67,604 I Held by The John Philip Coghlan 2025 Grantor Retained Annuity Trust
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 6, 2024. The Rule 10b5-1 trading plan is a pre-arranged written trading plan pursuant to which shares of Company stock are sold automatically based on a predetermined formula that was established by the Reporting Person at a time when the Reporting Person was not aware of any material nonpublic information about the Company.
2. The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $104.84 to $105.73, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.
3. The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $105.84 to $106.05, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.
4. Includes 2,508 restricted stock units, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.
Remarks:
/s/ Jay Sood, as Attorney-in-Fact 10/03/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Life360 director John Philip Coghlan report in the Form 4 (LIF)?

The Form 4 reports dispositions of common stock on 10/01/2025 effected under a Rule 10b5-1 plan, including sales of 2,701, 424, and 3,344 shares.

Were the sales pre-arranged or reactive to company news?

The filing states the trades were effected pursuant to a Rule 10b5-1 trading plan adopted on 12/06/2024, indicating they were pre-arranged.

At what prices were the shares sold according to the Form 4?

The filing reports weighted average prices of $105.28 (range $104.84$105.73) and $105.99 (range $105.84$106.05) for the stated transactions.

Do the transactions affect Coghlan's beneficial ownership?

Yes; the Form 4 shows changes in beneficial ownership and lists indirect holdings in the John Coghlan Living Trust and the John Philip Coghlan 2025 Grantor Retained Annuity Trust.

Does the Form 4 disclose restricted stock units?

Yes; a note states the 3,344-share disposition includes 2,508 restricted stock units that convert into shares upon vesting.
Life360 Inc

NASDAQ:LIF

LIF Rankings

LIF Latest News

LIF Latest SEC Filings

LIF Stock Data

5.68B
62.35M
2.29%
27.07%
4.76%
Software - Application
Services-computer Processing & Data Preparation
Link
United States
SAN MATEO